BlackRock Health Sciences Trust (BME)

BME Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Jun 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Net Income	-26.05	23.45	20.02	-26.47	59.12	79.56
Loss (Gain) From Sale of Investments	27.29	-22.39	-18.01	28.05	-59.12	-79.42
Other Operating Activities	80.43	63.95	30.77	-2.78	-21.8	-19.11
Change in Accounts Receivable	0.07	0.22	-0.02	-0.16	0.01	-0.04
Change in Income Taxes	-	-	-	-0.01	0.01	-
Change in Other Net Operating Assets	0.37	0.29	-0.75	0.5	0.23	-0.35
Operating Cash Flow	82.11	65.52	32.02	-0.87	-21.56	-19.35
Operating Cash Flow Growth	129.79%	104.63%	-	-	-	-
Short-Term Debt Issued	-	-	0.06	0	-	-
Total Debt Issued	-	-	0.06	0	-	-
Short-Term Debt Repaid	-	-0.06	-	-	-	-
Total Debt Repaid	-	-0.06	-	-	-	-
Net Debt Issued (Repaid)	-	-0.06	0.06	0	-	-
Issuance of Common Stock	-	-	3.02	33.62	50.33	45.09
Repurchase of Common Stock	-43.51	-29.53	-	-	-	-
Common Dividends Paid	-38.57	-35.92	-35.1	-32.73	-29	-25.65
Other Financing Activities	-	-	-0	-0.02	0.02	-
Financing Cash Flow	-82.08	-65.52	-32.02	0.88	21.34	19.44
Foreign Exchange Rate Adjustments	0	-0	-0	0	-0	-
Net Cash Flow	0.04	0.01	-0	0	-0.21	0.09
Cash Interest Paid	0	0	0	-	-	-
Levered Free Cash Flow	13.51	-2.15	4.66	-15.8	12.28	2.04
Unlevered Free Cash Flow	13.51	-2.15	4.66	-15.8	12.28	2.04
Change in Working Capital	0.45	0.51	-0.77	0.33	0.25	-0.39

Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q